Back

Assembly Bio shares rise 4.9% after exercising Gilead profit-share option

Verifying
  • Assembly Bio exercised its option to share U.S. development costs and profits with Gilead.
  • Shares rose 4.9% in after-hours trading Tuesday after the announcement.
  • Gilead’s plan calls for GS-1179 to enter Phase 2 trials by end-2026.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Assembly Bio shares rise 4.9% after exercising Gilead profit-share option - CoinPost Terminal